Abstract
Biological nanoparticles are considered to improve treatment with the least negative complications. Selenium nanoparticles have been used to treat diseases such as pathogenic infections and cancers. In this study, the effect of selenium nanoparticles on macrophage responses was evaluated. Selenium nanoparticles were synthesized biologically by Lactobacillus Plantarum and confirmed through TEM and SEM microscopy, EDX, and XRD characterizations. Macrophage cells were cultured and treated only with selenium nanoparticles and in combination with the bladder tumor lysate. Moreover, tumor lysate only was used as the other group. The genes expression of IFN-γ, IL-27, IL-12, and MHC-I was assessed by real-time PCR method. The production levels of IFN-γ and IL-27 cytokines were evaluated by ELISA assay. Selenium nanoparticles in combination with the tumor lysate increased the genes expression of IFN-γ, IL-27, IL-12, and MHC-I after 24 h and 48 h of treatment. Also, IFN-γ and IL-27 production was increased in the group treated with selenium nanoparticles in combination with the tumor lysate after 48 h and 72 h of treatment. The highest effect of selenium nanoparticles was observed after 48 and 72 h of treatment in the genes expression and cytokines production, respectively. Therefore, the optimum effect of selenium nanoparticle acts as a treatment dependent-manner.
Similar content being viewed by others
Availability of Data and Materials
Not applicable.
References
Beck MA, Levander OA, Handy J. J. Nutr. 2003;133(5):1463S-7S.
Schrauzer G.CMLS. 2000;57(13-14):1864-73.
Tapiero H, Townsend D, Tew K. Biomed. Pharmacother. 2003;57(3-4):134-44.
Zeng H, Combs Jr GF. J. Nutr. Biochem. 2008;19(1):1-7.
Guardado-Félix D, Antunes-Ricardo M, Rocha-Pizaña MR, Martínez-Torres A-C, Gutiérrez-Uribe JA, Saldivar SOS. J. Funct. Foods. 2019;53:76-84.
Kipp AP. Hormones. 2019:1-6.
Schrauzer G. Biol. Trace Elem. Res. 2006;109(3):281-92.
Schrauzer G. Biol. Trace Elem. Res. 2008;123(1-3):27-34.
Schrauzer G. Crit Rev Biotechnol. 2009;29(1):10-7.
Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigó R, et al. Science. 2003;300(5624):1439-43.
Sun Z, Xu Z, Wang D, Yao H, Li S. Metallomics. 2018;10(5):759-67.
Cherin P, Unger P. Inorg chem. 1967;6(8):1589-91.
Takahashi T. Physical Review B. 1982;26(10):5963.
Takahashi T, Yagi S, Sagawa T, Nagata K, Miyamoto Y. J Phys soc jpn. 1985;54(3):1018-22.
Yang L, Shen Y, Xie A, Liang J, Zhang B. Mater. Res. Bull. 2008;43(3):572-82.
Barabadi H, Tajani B, Moradi M, Kamali KD, Meena R, Honary S, et al. J. Clust. Sci. 2019:1–14.
Boomi P, Poorani GP, Palanisamy S, Selvam S, Ramanathan G, Ravikumar S, et al. J. Clust. Sci. 2019;30(3):715-26.
Kanagamani K, Muthukrishnan P, Shankar K, Kathiresan A, Barabadi H, Saravanan. J. Clust. Sci. 2019;30(6):1415-24.
Balachandar R, Gurumoorthy P, Karmegam N, Barabadi H, Subbaiya R, Anand K, et al. J. Clust. Sci. 2019;30(6):1481-8.
Barabadi H, Kamali KD, Shoushtari FJ, Tajani B, Mahjoub MA, Alizadeh A, et al. J. Clust. Sci. 2019:1–8.
Barabadi H, Vahidi H, Kamali KD, Rashedi M, Hosseini O, Ghomi ARG, et al. J. Clust. Sci. 2020;31(2):311-21.
Khatua A, Priyadarshini E, Rajamani P, Patel A, Kumar J, Naik A, et al. J. Clust. Sci. 2020;31(1):125-31.
برآبادی, حامد, حسینی, امید, کمالی, کاوه, et al. J. Clust. Sci. 31: 1.
Alam H, Khatoon N, Khan MA, Husain SA, Saravanan M, Sardar. J. Clust. Sci. 2020;31(5):1003-11.
Barabadi H, Alizadeh Z, Rahimi MT, Barac A, Maraolo AE, Robertson LJ, et al. Nanomed-nanotechnol. 2019;18:221-33.
Barabadi H. Cell Mol. Biol. 2017;63:3-4.
Ghomi ARG, Mohammadi-Khanaposhti M, Vahidi H, Kobarfard F, Reza MAS, Barabadi H. J. Pharm. Res. 2019;18(4):2101.
Honary S, Barabadi H, Ebrahimi P, Naghibi F, Alizadeh A, editors. Development and optimization of biometal nanoparticles by using mathematical methodology: A microbial approach. J. Nano Res. 2015: Trans Tech Publ.
Barabadi H, Najafi M, Samadian H, Azarnezhad A, Vahidi H, Mahjoub MA, et al. Medicina. 2019;55(8):439.
Mortezaee K, Najafi M, Samadian H, Barabadi H, Azarnezhad A, Ahmadi AJC-bi. Chem-Biol Interact. 2019;312:108814.
Zhang J, Wang X, Xu T. Toxicol. Sci. 2007;101(1):22-31.
Zhang J-S, Gao X-Y, Zhang L-D, Bao Y-P. Biofactors. 2001;15(1):27-38.
Singh P, Kim Y-J, Zhang D, Yang D-C. Trends Biotechnol. 2016;34(7):588-99.
Prasad K, Jha AK. J. Colloid Interface Sci. 2010;342(1):68-72.
Yazdi MH, Mahdavi M, Varastehmoradi B, Faramarzi MA, Shahverdi AR. Biol. Trace Elem. Res. 2012;149(1):22-8.
Jamkhande PG, Ghule NW, Bamer AH, Kalaskar. J. Drug Deliv. Sci. Technol. 2019;53:101174.
Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, et al. Cell. 2018;172(1-2):176-90. e19.
von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, et al. J. Clin. Oncol. 2005;23(21):4602-8.
Drake CG, Jaffee E, Pardoll DM. Adv immunol. 2006;90:51-81.
Luo Y, Yamada H, Chen X, Ryan A, Evanoff D, Triccas J, et al. Clin. Exp. Immunol. 2004;137(1):24-34.
Catalán E, Charni S, Jaime P, Aguiló JI, Enríquez JA, Naval J, et al. Oncoimmunology. 2015;4(1):e985924.
Choi J-N, Sun EG, Cho S-H. Chonnam Med. J. 2019;55(1):31-9.
Liu Z, Yu J, Carson III WE, Bai X-F. Am. J. Transl. Res. 2013;5(5):470.
Yin L, Fang Z, Shen N-j, Qiu Y-h, Li A-j, Zhang Y-J. Drug des, dev ther. 2017;11:2841.
Banete A, Achita P, Harding K, Mulder R, Basta S. J. Clin. Cell Immunol. 2015;6(318.10):4172.
Schneider R, Yaneva T, Beauseigle D, El‐Khoury L, Arbour N. Eur J Immunol. 2011;41(1):47-59.
Wang Q, Ning H, Peng H, Wei L, Hou R, Hoft DF, et al. Nat. Commun. 2017;8(1):867.
Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, et al. Cancer immunol res. 2019;7(8):1237-43.
Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ. Blood. 2000;96(5):1857-64.
Shakibaie M, Forootanfar H, Mollazadeh‐Moghaddam K, Bagherzadeh Z, Nafissi‐Varcheh N, Shahverdi AR, et al. Biotechnol. Appl. Bioc. 2010;57(2):71-5.
Dhanjal S, Cameotra SS. Microb Cell Fact. 2010;9(1):52.
Ingole AR, Thakare SR, Khati N, Wankhade AV, Burghate D. Green synthesis of selenium nanoparticles under ambient condition. Chalcogenide Lett. 2010;7(7):485-9.
Barabadi H, Vahidi H, Kamali KD, Rashedi M, Saravanan.J. Clust. Sci. 2020;31(4):659-72.
Barabadi H, Vahidi H, Mahjoub MA, Kosar Z, Kamali KD, Ponmurugan K, et al. J. Clust. Sci. 2019:1–12.
Khatua A, Prasad A, Priyadarshini E, Patel AK, Naik A, Saravanan M, et al. J. Clust. Sci. 2019:1–12.
Virmani I, Sasi C, Priyadarshini E, Kumar R, Sharma SK, Singh GP, et al. J. Clust. Sci. 2019:1–10.
Fard NN, Noorbazargan H, Mirzaie A, Hedayati Ch M, Moghimiyan Z, Rahimi A. Artif. Cells Nanomed. Biotechnol. 2018;46(sup3):S1047-S58.
Barabadi H, Vahidi H, Damavandi Kamali K, Rashedi M, Hosseini O, Saravanan. J. Clust. Sci. 2020;31(4):651-8.
Vahidi H, Barabadi H, Saravanan. J. Clust. Sci. 2020;31(2):301-9.
Rajeshkumar S, Ganesh L, Santhoshkumar J. Selenium nanoparticles as therapeutic agents in neurodegenerative diseases. Nanobiotechnol. Neurodegen. Dis. 2019. p. 209–24.
Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat immunol. 2010;11(10):889.
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Nat immunol. 2008;9(5):503.
Yazdi MH, Varastehmoradi B, Faghfuri E, Mavandadnejad F, Mahdavi M, Shahverdi AR. J. Nanosci. Nanotechnol. 2015;15(12):10165-72.
Brunda MJ, Luistro L, Hendrzak JA, Fountoulakis M, Garotta G, Gately MK. J. Immunother. Emphasis Tumor Immunol.. 1995;17(2):71-7.
Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y, et al. Cancer Res. 2004;64(3):1152-6.
O’donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK. J. Urol. 2004;171(3):1330-5.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, et al. Immunity. 1998;9(1):25-34.
Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD, Jr. J. Exp Med. 1996;183(1):283-7.
Garrido F, Aptsiauri N, Doorduijn EM, Garcia Lora AM, van Hall T. Curr. Opin. Immunol. 2016;39:44-51.
Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Br. J. Cancer. 1996;73(2):148-53.
Brucet M, Marques L, Sebastian C, Lloberas J, Celada A. Genes Immun. 2004;5(1):26-35.
Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, et al. Cancer Immunol. Res. 2019;7(8):1237-43.
Acknowledgements
This work was supported by: National Natural Science Foundation of China, 81502205, China Postdoctoral Science Foundation Grant, 2018M631175. Science Incubation Found of Shaanxi Provincial People’s Hospital, 2015YX-2. National Natural Science Foundation of Shaanxi, 2017JM8093. National Natural Science Foundation of Shaanxi, 2019JM-069. Shaanxi key research and development program, 2017ZDXM-SF-050. The projects 1, 2, 4, and 5 were awarded to Liang Liang. Projects 3 and 6 were awarded to Sun Yi
Author information
Authors and Affiliations
Contributions
SY and LL designed study. PL and DQ performed the assays. GZ and CY analyzed data. All the authors contributed to write and revise the manuscript.
Corresponding authors
Ethics declarations
Conflicts of interest
The author declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liang, P., Qian, D., Zhenfeng, G. et al. Biological Selenium Nano-particles Modify Immune Responses of Macrophages Exposed to Bladder Tumor Antigens. J Clust Sci 32, 1623–1633 (2021). https://doi.org/10.1007/s10876-020-01920-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-020-01920-6